CFH rs1410996: Understanding Your Genetic Association with AMD
The rs1410996 variant is a common genetic polymorphism located within the CFH gene, which plays a critical role in regulating the body's immune response. Research has consistently associated this variant with varying levels of susceptibility to age-related macular degeneration (AMD).
What each genotype means
Lower AMD risk profile
Research indicates that this genotype is associated with a decreased risk of developing age-related macular degeneration (AMD) compared to other genotypes. This variant is located in the CFH gene, which plays a role in the immune system's complement pathway, though the exact biological mechanism remains a subject of ongoing study.
This genotype is common, though its specific frequency varies significantly across different global ancestral populations.
Intermediate AMD risk profile
This genotype represents a heterozygous state for the rs1410996 variant. Studies suggest that individuals with this genotype may have an intermediate risk profile for age-related macular degeneration compared to those who are homozygous for either the risk or protective alleles.
This is a common genotype found in many populations worldwide, often serving as a frequent intermediate state in genetic studies of the CFH gene.
Higher AMD risk profile
This genotype has been associated with an increased susceptibility to age-related macular degeneration (AMD) in various studies. While this variant is a known marker for risk, it is important to remember that AMD is a complex condition influenced by many genetic and environmental factors; having this genotype does not mean you will develop the disease.
This genotype is common and is frequently observed in both healthy control groups and individuals diagnosed with AMD across diverse ancestral backgrounds.
What is rs1410996?
The rs1410996 variant is a single nucleotide polymorphism (SNP) found within the CFH gene on chromosome 1. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in a non-coding region of the gene, meaning it does not directly alter the amino acid sequence of the protein produced. Instead, researchers study such variants to understand how they might influence gene expression or how they serve as markers for other nearby genetic changes that do affect protein function. Because it is a common variant, it is frequently analyzed in large-scale genetic studies to determine its statistical relationship with complex health conditions, particularly those involving the eye.
The Role of the CFH Gene
The CFH gene provides instructions for making a protein called complement factor H. This protein is a vital component of the complement system, which is part of the innate immune system. The complement system helps the body identify and clear away pathogens and damaged cells. Complement factor H specifically acts as a regulator, preventing the complement system from becoming overactive and damaging the body's own healthy tissues. When the regulation of this system is impaired, it can lead to chronic inflammation. In the context of the eye, the complement system is highly active in the retina. Proper regulation is essential for maintaining retinal health, and dysfunction in this pathway is a well-documented factor in the development of age-related macular degeneration (AMD).
Research and Evidence Strength
The association between rs1410996 and AMD has been the subject of numerous studies across diverse populations, including European, Asian, and Brazilian cohorts. Meta-analyses have indicated that this variant is statistically associated with AMD risk, though the strength of this association can vary by population and study design. Some research suggests that the variant may be linked to differences in serum levels of complement factor H, which could influence disease susceptibility. However, it is important to note that the evidence is considered limited in terms of clinical predictability. Many researchers emphasize that rs1410996 often exists in linkage disequilibrium with other functional variants, meaning it may simply be a marker for other, more directly causative genetic changes in the CFH-CFHR region. Consequently, while it is a useful tool for research, it is not currently used as a standalone diagnostic test.
Population Frequency
The rs1410996 variant is considered a common polymorphism, meaning it is found at relatively high frequencies across many global populations. Because it is common, most individuals will carry at least one copy of the variant. The specific distribution of the G and A alleles varies by ancestry, which is why researchers often conduct population-specific studies to confirm the strength of the association with AMD. In many studies, the G allele is frequently investigated as the risk-associated allele, while the A allele is often associated with lower odds of disease, though these patterns are not universal and depend heavily on the genetic background of the group being studied.
What This Information Means for You
If you have received information about your rs1410996 genotype, it is important to view it in the context of complex disease genetics. AMD is a multifactorial condition, meaning it is influenced by a combination of genetics, environmental factors, and lifestyle choices, such as smoking and diet. A specific genotype does not guarantee that an individual will or will not develop AMD. This information is intended for educational purposes and should not be used to diagnose or predict personal health outcomes. If you have concerns about your eye health or a family history of macular degeneration, the most appropriate step is to consult with an ophthalmologist or a genetic counselor. They can provide a comprehensive assessment based on your clinical history and current eye health, rather than relying on a single genetic marker.
How common is this variant?
The rs1410996 variant is a common polymorphism found across diverse global populations, with allele frequencies varying significantly by ancestry.
Frequently asked questions
Does having the GG genotype mean I will get AMD?
No. AMD is a complex disease influenced by many factors, including age, smoking, and other genetic variants. A single genotype at rs1410996 is not a diagnostic tool and cannot predict whether you will develop the condition.
Can I change my risk associated with this variant?
While you cannot change your genetics, you can manage modifiable risk factors for AMD. Maintaining a healthy diet, avoiding smoking, and scheduling regular eye exams with an eye care professional are recommended strategies for overall eye health.
Is rs1410996 the only genetic factor for AMD?
No, AMD is associated with many different genetic variants, particularly those in the CFH and ARMS2/HTRA1 gene regions. These variants often work together to influence your overall genetic risk profile.
Should I get tested for this SNP?
Genetic testing for AMD-associated variants is generally not recommended for the general population. If you are concerned about your risk, discuss your family history and eye health with an ophthalmologist.
Sources & further reading
Educational information only, last refreshed 11/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1410996?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CFH
This variant in the complement factor H gene is associated with altered regulation of the alternative complement pathway and increased susceptibility to age-related macular degeneration.
This regulatory variant in the CFH locus is linked to complement system dysregulation and is a recognized genetic risk factor for age-related macular degeneration.
Intronic single nucleotide variant in the CFH region associated with susceptibility to age-related macular degeneration (AMD).
Common variant in the CFH locus strongly associated with risk of age-related macular degeneration (AMD).
Genomic marker in CFH frequently co-inherited in haplotypes modulating risk of late-stage visual loss from macular degeneration.
Intergenic/intronic variant within the CFH cluster contributing to phenotypic variation in retinal complement activation.